|
Feb 02, 2023
|
AC Immune to Present at the SVB Securities Global Biopharma Conference
|
|
|
Jan 26, 2023
|
AC Immune’s ACI-24.060 Anti-Amyloid Beta Vaccine for Alzheimer’s Shows Positive Initial Interim Safety and Immunogenicity in Phase 1b/2 ABATE Trial
|
|
|
Jan 18, 2023
|
AC Immune Partner Life Molecular Imaging Initiates Phase 3 Study of Tau PET Diagnostic PI-2620 for Alzheimer’s Disease
|
|